Professor Takeshi Kimura
Hirakata Kohsai Hospital, Hirakata (Japan)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Stent type and duration of dual antiplatelet therapy.
Event: ESC Congress 2018
Topic: Stents
Session: Safer stents and strategies: is it time for the de-escalation of dual antiplatelet treatment regimes?
Optimal antithrombotic treatment beyond the first year post PCI for ACS
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Expert Advice - Antithrombotic therapy after acute coronary syndromes
Imaging for bioresorbable scaffolds - An Asian perspective
Event: ESC Congress 2016
Topic: PCI / stents: devices and technique
Session: Bioresorbable vascular scaffold
ABSORB Japan: 2-year clinical results from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent in de novo native coronary artery lesions
Event: ESC Congress 2016
Topic: PCI / stents: devices and technique
Session: Clinical Trial Update Coronary artery disease
Future direction for research in complex PCI.
Event: ESC Congress 2016
Topic: PCI / stents: devices and technique
Session: PCI in challenging anatomies
ESC 365 is supported by
